{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:11:11Z","timestamp":1783195871450,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key R&D Project in Shanxi Province","award":["201803D31116"],"award-info":[{"award-number":["201803D31116"]}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["No.2012011040-3"],"award-info":[{"award-number":["No.2012011040-3"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["No.2013011049-4"],"award-info":[{"award-number":["No.2013011049-4"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Project for Science and Technology Achievements Transformation of Shanxi","award":["201804D131046"],"award-info":[{"award-number":["201804D131046"]}]},{"name":"Scientific Research Foundation of High Education Institutions of Shanxi Province","award":["200811034"],"award-info":[{"award-number":["200811034"]}]},{"name":"Research Project of Shanxi Provincial Health and Family Planning Commission","award":["No. 201602026"],"award-info":[{"award-number":["No. 201602026"]}]},{"name":"Research Project of Shanxi Provincial Health and Family Planning Commission","award":["No.201602028"],"award-info":[{"award-number":["No.201602028"]}]},{"name":"Research Project of Shanxi Provincial Health and Family Planning Commission","award":["No.2017049"],"award-info":[{"award-number":["No.2017049"]}]},{"name":"Doctoral Initiation Funding of the Second Hospital of Shanxi Medical University","award":["EY2018"],"award-info":[{"award-number":["EY2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1966-4","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T13:53:44Z","timestamp":1562853224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Shu-Ling","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"issue":"14","key":"1966_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807\u201316.","journal-title":"Circulation"},{"issue":"16","key":"1966_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810\u201352.","journal-title":"Circulation"},{"issue":"23","key":"1966_CR3","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850\u20138.","journal-title":"Eur Heart J"},{"issue":"17","key":"1966_CR4","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/0002-9149(92)90901-A","volume":"69","author":"TA Manolio","year":"1992","unstructured":"Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (Summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol. 1992;69(17):1458\u201366.","journal-title":"Am J Cardiol"},{"key":"1966_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1172-1-27","volume":"1","author":"MR Taylor","year":"2006","unstructured":"Taylor MR, Carniel E, Mestroni L. Mestroni, cardiomyopathy, familial dilated. Orphanet J Rare Dis. 2006;1:27.","journal-title":"Orphanet J Rare Dis."},{"issue":"19","key":"1966_CR6","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388\u2013442.","journal-title":"Eur Heart J"},{"issue":"18","key":"1966_CR7","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.jacc.2015.09.010","volume":"66","author":"AA Kelkar","year":"2015","unstructured":"Kelkar AA, Butler J, Schelbert EB, et al. Mechanisms contributing to the progression of ischemic and nonischemic dilated cardiomyopathy: possible modulating effects of paracrine activities of stem cells. J Am Coll Cardiol. 2015;66(18):2038\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1966_CR8","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1056\/NEJMoa060186","volume":"355","author":"V Sch\u00e4chinger","year":"2006","unstructured":"Sch\u00e4chinger V, Erbs S, Els\u00e4sser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355(12):1210\u201321.","journal-title":"N Engl J Med"},{"issue":"12","key":"1966_CR9","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1056\/NEJMoa051779","volume":"355","author":"B Assmus","year":"2006","unstructured":"Assmus B, Honold J, Sch\u00e4chinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355(12):1222\u201332.","journal-title":"N Engl J Med"},{"issue":"10","key":"1966_CR10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.amjcard.2003.08.002","volume":"92","author":"M Canetti","year":"2003","unstructured":"Canetti M, Akhter MW, Lerman A, et al. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol. 2003;92(10):1246\u20139.","journal-title":"Am J Cardiol"},{"issue":"8","key":"1966_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"JR Duran","year":"2007","unstructured":"Duran JR, Taffet G. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830\u201340.","journal-title":"N Engl J Med"},{"issue":"5","key":"1966_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023","volume":"2","author":"U Fischer-Rasokat","year":"2009","unstructured":"Fischer-Rasokat U, Assmus B, Seeger FH, et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail. 2009;2(5):417\u201323.","journal-title":"Circ Heart Fail."},{"issue":"1","key":"1966_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijcard.2005.09.055","volume":"111","author":"P Widimsky","year":"2006","unstructured":"Widimsky P, Penicka M. Complications after intracoronary stem cell transplantation in idiopathic dilated cardiomyopathy. Int J Cardiol. 2006;111(1):178\u20139.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1966_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cardfail.2010.11.007","volume":"17","author":"B Vrtovec","year":"2011","unstructured":"Vrtovec B, Poglajen G, Sever M, et al. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail. 2011;17(4):272\u201381.","journal-title":"J Card Fail."},{"issue":"16","key":"1966_CR15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jacc.2010.05.039","volume":"56","author":"N Beohar","year":"2010","unstructured":"Beohar N, Rapp J, Pandya S, Losordo DW. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol. 2010;56(16):1287\u201397.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1966_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.108.180463","volume":"103","author":"T Ziebart","year":"2008","unstructured":"Ziebart T, Yoon CH, Trepels T, et al. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 2008;103(11):1327\u201334.","journal-title":"Circ Res"},{"issue":"10","key":"1966_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1590\/S0100-879X2010007500093","volume":"43","author":"HF Martino","year":"2010","unstructured":"Martino HF, Oliveira PS, Souza FC, et al. A safety and feasibility study of cell therapy in dilated cardiomyopathy. Braz J Med Biol Res. 2010;43(10):989\u201395.","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"1966_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med."},{"key":"1966_CR19","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"15","key":"1966_CR20","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jacc.2009.11.070","volume":"55","author":"S Seth","year":"2010","unstructured":"Seth S, Bhargava B, Narang R, et al. The ABCD (autologous bone marrow cells in dilated cardiomyopathy) trial a long-term follow-up study. J Am Coll Cardiol. 2010;55(15):1643\u20134.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1966_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","volume":"112","author":"B Vrtovec","year":"2013","unstructured":"Vrtovec B, Poglajen G, Lezaic L, et al. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res. 2013;112(1):165\u201373.","journal-title":"Circ Res"},{"issue":"8","key":"1966_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/CIRCRESAHA.115.304554","volume":"115","author":"TD Henry","year":"2014","unstructured":"Henry TD, Traverse JH, Hammon BL, et al. Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy. Circ Res. 2014;115(8):730\u20137.","journal-title":"Circ Res"},{"issue":"3","key":"1966_CR23","first-page":"437","volume":"29","author":"RT Sant\u2019Anna","year":"2014","unstructured":"Sant\u2019Anna RT, Fracasso J, Valle FH, et al. Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial. Rev Bras Cir Cardiovasc. 2014;29(3):437\u201347.","journal-title":"Rev Bras Cir Cardiovasc."},{"issue":"42","key":"1966_CR24","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","volume":"36","author":"H Martino","year":"2015","unstructured":"Martino H, Brofman P, Greco O, et al. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study). Eur Heart J. 2015;36(42):2898\u2013904.","journal-title":"Eur Heart J"},{"issue":"2","key":"1966_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1536\/ihj.16-328","volume":"58","author":"W Xiao","year":"2017","unstructured":"Xiao W, Guo S, Gao C, et al. A randomized comparative study on the efficacy of intracoronary infusion of autologous bone marrow mononuclear cells and mesenchymal stem cells in patients with dilated cardiomyopathy. Int Heart J. 2017;58(2):238\u201344.","journal-title":"Int Heart J."},{"issue":"44","key":"1966_CR26","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","volume":"36","author":"S Hamshere","year":"2015","unstructured":"Hamshere S, Arnous S, Choudhury T, et al. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. Eur Heart J. 2015;36(44):3061\u20139.","journal-title":"Eur Heart J"},{"key":"1966_CR27","doi-asserted-by":"publisher","first-page":"746873","DOI":"10.1155\/2015\/746873","volume":"2015","author":"T Fatkhudinov","year":"2015","unstructured":"Fatkhudinov T, Bolshakova G, Arutyunyan I, et al. Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle. Stem Cells Int. 2015;2015:746873.","journal-title":"Stem Cells Int."},{"key":"1966_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.114.001614","author":"S Yamada","year":"2015","unstructured":"Yamada S, Arrell DK, Martinez-Fernandez A, Behfar A, Kane GC, Perez-Terzic CM, et al. Regenerative therapy prevents heart failure progression in dyssynchronous nonischemic narrow QRS cardiomyopathy. J Am Heart Assoc. 2015. \n                    https:\/\/doi.org\/10.1161\/jaha.114.001614\n                    \n                  .","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1966_CR29","first-page":"1463","volume":"35","author":"R Jiao","year":"2014","unstructured":"Jiao R, Liu Y, Yang WJ, et al. Effects of stem cell therapy on dilated cardiomyopathy. Saudi Med J. 2014;35(12):1463\u20138.","journal-title":"Saudi Med J"},{"issue":"2","key":"1966_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/07853890601145821","volume":"39","author":"S Karkkainen","year":"2007","unstructured":"Karkkainen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med. 2007;39(2):91\u2013107.","journal-title":"Ann Med"},{"issue":"23","key":"1966_CR31","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1056\/NEJM200106073442303","volume":"344","author":"AP Beltrami","year":"2001","unstructured":"Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344(23):1750\u20137. \n                    https:\/\/doi.org\/10.1056\/NEJM200106073442303\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"8","key":"1966_CR32","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.104.500447","volume":"112","author":"N Nagaya","year":"2005","unstructured":"Nagaya N, Kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. 2005;112(8):1128\u201335.","journal-title":"Circulation"},{"issue":"11","key":"1966_CR33","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2006.07.057","volume":"48","author":"S Seth","year":"2006","unstructured":"Seth S, Narang R, Bhargava B, et al. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (autologous bone marrow cells in dilated cardiomyopathy) trial. J Am Coll Cardiol. 2006;48(11):2350\u20131.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1966_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0735-1097(03)00911-2","volume":"42","author":"DA Cox","year":"2003","unstructured":"Cox DA, Stone GW, Grines CL, et al. Outcomes of optimal or \u201cstent-like\u201d balloon angioplasty in acute myocardial infarction: the CADILLAC trial. J Am Coll Cardiol. 2003;42(6):971\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"1966_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMoa013404","volume":"346","author":"RJ Aviles","year":"2002","unstructured":"Aviles RJ, Askari AT, Lindahl B, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346(13):957\u201366.","journal-title":"N Engl J Med"},{"issue":"4","key":"1966_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ahj.2011.06.019","volume":"162","author":"JH Traverse","year":"2011","unstructured":"Traverse JH, Henry TD, Moye\u2019 LA. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging. Am Heart J. 2011;162(4):671\u20137.","journal-title":"Am Heart J"},{"issue":"24","key":"1966_CR37","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","volume":"112","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, Anavekar N, Skali H, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112(24):3738\u201344.","journal-title":"Circulation"},{"issue":"2","key":"1966_CR38","first-page":"CD006536","volume":"15","author":"DM Clifford","year":"2012","unstructured":"Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012;15(2):CD006536.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1966_CR39","doi-asserted-by":"publisher","first-page":"e37373","DOI":"10.1371\/journal.pone.0037373","volume":"7","author":"DM Clifford","year":"2012","unstructured":"Clifford DM, Fisher SA, Brunskill SJ, et al. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PLoS ONE. 2012;7(5):e37373.","journal-title":"PLoS ONE"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1966-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T23:19:41Z","timestamp":1594336781000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1966"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1966-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"27 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}